# Study Evaluating Single Doses of BLI-489 in Healthy Japanese Male Subjects

> **NCT00854009** · PHASE1 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BLI-489
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00854009
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02-20
- **Primary completion:** 2009-04-01
- **Final completion:** 2009-04-27
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00854009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00854009, "Study Evaluating Single Doses of BLI-489 in Healthy Japanese Male Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00854009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*